Interestingly, we found that CMTM6/CMTM4 and PD-L1 co-localized in macrophages are associated with lower OS in glioma, suggesting that CMTM6/CMTM4 may be specific companion diagnostic biomarkers for immunotherapy in gliomas. This evidence concerns the gene CD274 and central nervous system cancer.